Clinical trial
Chemotherapy in Treating Patients With Sarcoma of the Uterus
NCT00005643 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005643 |
|---|---|
| Title | Chemotherapy in Treating Patients With Sarcoma of the Uterus |
| Official title | Evaluation of Doxil in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer, Sarcoma |
| Intervention type | Drug |
| Interventions | pegylated liposomal doxorubicin hydrochloride |
| Start date | May 1, 2000 |
| Primary completion | Mar 1, 2005 |
| First posted | Apr 19, 2004 |
| Last update posted | Jun 10, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: